Medicus Pharma (MDCX) Cash Flow: Operating & Free Cash Flow

Medicus Pharma Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Medicus Pharma Ltd. (MDCX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Operating Activities
Net Income	-35.44	-11.16	-5.31	-1.69	-2.06
Stock Based Compensation	1.51	0.71	0.10	0.00	0.00
Change in Working Capital	0.41	0.03	0.47	-0.08	-0.01
Change in Accounts Payable	0.92	0.81	0.08	0.00	-0.01
Change in Other Working Capital	0.18	-1.05	0.01	-0.08	0.61
Other Operating Activities	10.49	0.07	0.58	0.71	0.61
Net Cash from Operating Activities	-22.78	-10.25	-4.16	-1.06	-1.45
Investing Activities
Acquisitions	-4.62	0.00	0.00	0.00	0.00
Net Cash from Investing Activities	-4.62	0.00	0.00	0.00	0.00
Financing Activities
Debt Repayment	-7.39	5.17	0.50	1.25	0.88
Common Stock Issued	28.25	7.52	5.11	0.00	0.00
Other Financing Activities	-0.79	0.00	5.11	0.00	0.00
Net Cash from Financing Activities	31.94	12.69	5.61	1.25	0.88
Summary
Effect of Forex Changes on Cash	0.00	0.00	0.00	0.00	0.00
Net Change in Cash	4.54	2.44	1.45	0.19	-0.57
Cash at Beginning of Period	4.16	1.72	0.27	0.08	0.64
Cash at End of Period	8.71	4.16	1.72	0.27	0.08
Free Cash Flow	-22.78	-10.25	-4.16	-1.06	-1.45

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Medicus Pharma Cash Flow

What is Medicus Pharma's free cash flow?

Medicus Pharma had negative free cash flow of $22.78M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does Medicus Pharma pay dividends or buy back shares?

Medicus Pharma's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition